Loading...

ROSSARI Rossari Biotech Ltd Changes in management or control Announcement

Rssr

RSSR

Rossari Biotech Ltd

(ROSSARI)

2025 Announcement

Leasehold land transfer

Earnings Call Transcript

Earnings Call Audio

Financial Results Published

Q2 FY26 Results

Q2 FY26 Presentation

Financial Update

Stock Options Granted

Financial Results Released

Board Meeting Outcome

Earnings Call Notice

Compliance Certificate

Capacity Expansion

Share Acquisition

Share Acquisition Disclosure

Share Acquisition Disclosure

Share Transfer Announcement

Share Transfer Announcement

Investor Call Update

Land Acquisition

Earnings Call Transcript

Earnings Call Audio

Q1 FY26 Results

Q1 FY26 Earnings

Financial Results Publication

Earnings Call Scheduled

Compliance Certificate

Notice to Shareholders

AGM Notice Published

Annual Compliance Report

Investor Call Cancellation

Investor Meetings

Management Resignation

Earnings Call Transcript

Earnings Call Recording

Financial Results Publication

Q4 FY25 Results

Earnings Presentation

Financial Results Approved

New Auditor Appointment

Employee Stock Options

Capacity Expansion

Change in RTA Details

Compliance Certificate

Favorable GST Appeal

Investor Meeting

Favorable Ruling

Q3 FY25 Earnings Call

Earnings Call Recording

Q3 FY25 Results

Earnings Presentation

Financial Results Release

Office Relocation

Earnings Call Scheduled

Compliance Certificate

RTA Name Change

New Subsidiary Established

Acquisition Completed

Director Retirement

Investor Meetings

Earnings Call Update

Credit Rating Reaffirmed

Earnings Call Recording

EGM Notice Published

Extraordinary Meeting Notice

Financial Results Update

Earnings Presentation

Q2 FY25 Results

Earnings Presentation

Equity Share Allotment

Capacity Expansion Update

Earnings Call Announcement

Compliance Certificate

New Subsidiary Creation

Investor Meeting

Investor Meeting

Advertisement Publication

Earnings Call Transcript

Publication of AGM Notice

Equity Shares Allotment und...

Financial Results Publication

Financial Results Announcement

Earnings Presentation

Equity Shares Allotment und...

Earnings Conference Call

Compliance Certificate Subm...

Investor Conference

Acquisition Update

Annual Secretarial Compliance

Investor Meet Intimation

Demise Announcement

Earnings Call Update

Earnings Conference Call Ou...

Publication of Financial Re...

Financial Results Disclosure

Earnings Presentation

Stock Options Grant

Compliance Certificate Subm...

Compliance Certificate Subm...

Compliance Certificate Subm...

Conference Participation

Newspaper Publication

Earnings Presentation

Rossari Biotech Q3 FY24 Res...

Allotment of Equity Shares ...

Earnings Conference Call

Conference Call

Compliance Certificate Subm...

Penalty Imposed

Arbitration Proceeding Init...

Investor Conference

Investor Meeting

Record Q2 FY24 Earnings

Audio Recording of Earnings...

Earnings Presentation

Q2 FY24 Press Release

Allotment of Equity Shares

Capacity Expansion

Earnings Conference Call

Penalty Imposed

Dematerialisation Confirmation

Analyst/Investor Meet

Subsidiary Incorporation

Conference Participation

Earnings Conference Call

Financial Statements

Financial Statements

Re-classification of Senior...

Equity Offerings

Credit Ratings Reaffirmation

Compliance Certificate

Management Changes

Investor Meetings

Management Changes

Employee Stock Options

Management Changes

Management Changes

Availability of audio recor...

Financial Results Publication

External Links:

Data:

Rossari Biotech Ltd appointed M/s. Shah Patel & Associates as their Secretarial Auditor and approved a final dividend of 25% (Re. 0.50 per share) for FY 2024-25 during the Board meeting on April 25, 2025.

AI Assistant

Rossari Biotech Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.